Tumor microenvironment improved by nanostructured lipid carriers co-deliverying paclitaxel and ubenimex to treat breast cancer.
OBJECTIVE The aim of this research was to design nanostructured lipid carriers co-delivering paclitaxel and ubenimex to improve the tumor microenvironment and enhance efficacy against breast cancer. SIGNIFICANCE Nanostructured lipid carriers (NLC) offer unique advantages for co-delivery of anti-tumor drugs, including...